Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Kathleen Yost"'
Autor:
Alissa M. Michel, Haeseung Yi, Jacquelyn Amenta, Nicole Collins, Anna Vaynrub, Subiksha Umakanth, Garnet Anderson, Katie Arnold, Cynthia Law, Sandhya Pruthi, Ana Sandoval-Leon, Rachel Shirley, Maria Grosse Perdekamp, Sarah Colonna, Stacy Krisher, Tari King, Lisa D. Yee, Tarah J. Ballinger, Christa Braun-Inglis, Debra A. Mangino, Kari Wisinski, Claudia A. DeYoung, Masey Ross, Justin Floyd, Andrea Kaster, Lindi VanderWalde, Thomas J. Saphner, Corrine Zarwan, Shelly Lo, Cathy Graham, Alison Conlin, Kathleen Yost, Doreen Agnese, Cheryl Jernigan, Dawn L. Hershman, Marian L. Neuhouser, Banu Arun, Katherine D. Crew, Rita Kukafka
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 24, Iss 1, Pp 1-15 (2024)
Abstract Background Women with high-risk breast lesions, such as atypical hyperplasia (AH) or lobular carcinoma in situ (LCIS), have a 4- to tenfold increased risk of breast cancer compared to women with non-proliferative breast disease. Despite high
Externí odkaz:
https://doaj.org/article/7ac042041f3a4b14993e75986bbff3f6
Autor:
Joel E. Pacyna, Simon Kim, Kathleen Yost, Hillary Sedlacek, Daniel Petereit, Judith Kaur, Bruce Rapkin, Robert Grubb, Electra Paskett, George J. Chang, Jeff Sloan, Ethan Basch, Brittny Major, Paul Novotny, John Taylor, Jan Buckner, J. Kellogg Parsons, Michael Morris, Jon C. Tilburt
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background Treatments for localized prostate cancer present challenging tradeoffs in the face of uncertain treatment benefits. These options are best weighed in a process of shared decision-making with the patient’s healthcare team. Minori
Externí odkaz:
https://doaj.org/article/b458e00a61a143f4a177e89ecfa99585
Autor:
Katherine D. Crew, Garnet Anderson, Kathryn Arnold, Andrew Stieb, Jacquelyn N. Amenta, Cynthia Law, Ana Sandoval-Leon, Sarah Colonna, Tari King, Debra Mangino, Sandhya Pruthi, Maria Grosse Perdekamp, Christa Braun-Inglis, Stacy Krisher, Lisa Yee, Danielle Bertoni, Samantha Seaward, Kari B. Wisinski, Justin Floyd, Corrine Zarwan, Tarah J. Ballinger, Lindi VanderWalde, Masey M. Ross, Preston Steen, Shelly Lo, Alison Conlin, Kathleen Yost, John Ellerton, Erin Lin, Holly J. Pederson, Sagar Sardesai, Cheryl Jernigan, Dawn Hershman, Marian L. Neuhouser, Banu K. Arun, Rita Kukafka
Publikováno v:
Cancer Research. 83:OT1-15
Background: Despite evidence of substantial breast cancer risk reduction, few high-risk women adopt chemopreventive medications such as selective estrogen receptor modulators (SERMs) or aromatase inhibitors (AIs). Women with benign breast disease, su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7073655dcd5e0cc9ecc26e2048e4ecbe
https://doi.org/10.1158/1538-7445.sabcs22-ot1-15-01
https://doi.org/10.1158/1538-7445.sabcs22-ot1-15-01
Autor:
Surbhi Sidana, Cristine Allmer, Melissa C. Larson, Amylou Dueck, Kathleen Yost, Rahma Warsame, Gita Thanarajasingam, James R. Cerhan, Jonas Paludo, S. Vincent Rajkumar, Thomas M. Habermann, Grzegorz S. Nowakowski, Yi Lin, Morie A. Gertz, Thomas Witzig, Angela Dispenzieri, Wilson I. Gonsalves, Stephen M. Ansell, Carrie A. Thompson, Shaji K. Kumar
Publikováno v:
JCO oncology practice. 18(8)
PURPOSE: Patients' concerns regarding clinical trial (CT) participation include apprehension about side effects, quality of life (QoL), financial burden, and quality of care. METHODS: We prospectively evaluated the experience of patients with multipl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce9b45a5e5aab7eda49be7cd21ea7c33
https://pubmed.ncbi.nlm.nih.gov/35580285
https://pubmed.ncbi.nlm.nih.gov/35580285
Autor:
Surbhi Sidana, Amylou C. Dueck, Gita Thanarajasingam, Joan M. Griffin, Carrie Thompson, Urshila Durani, Michelle Burtis, Rahma Warsame, Jonas Paludo, Morie A. Gertz, Angela Dispenzieri, Stephen M. Ansell, S. Vincent Rajkumar, Kathleen Yost, Nora Bennani, Yi Lin, Shaji Kumar
Publikováno v:
Transplantation and cellular therapy. 28(8)
There are limited data on patient experience after chimeric antigen receptor (CAR) T-cell therapy, especially in comparison to autologous and allogeneic transplantation, which are more established forms of cellular therapy. We prospectively evaluated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f82530a0bbe8c4de013cdf277d44666
https://pubmed.ncbi.nlm.nih.gov/35914900
https://pubmed.ncbi.nlm.nih.gov/35914900
Autor:
Kevin P. Becker, John D. Hainsworth, Tarek Mekhail, David Wright, Howard A. Burris, Sajeel A. Chowdhary, Janice Faulkner Eakle, Kimberly West-Osterfield, Gilbert Darin Anthony Padula, Mythili Shastry, Meredith Scarberry, Kent C. Shih, Robert M. Langdon, Candice A. Shaifer, Kathleen Yost
Publikováno v:
Journal of Neuro-Oncology. 144:303-311
Current bevacizumab-based regimens have failed to improve survival in patients with recurrent glioblastoma. To improve treatment efficacy, we evaluated bevacizumab + BKM120, an oral pan-class I PI3K inhibitor, in this patient population. A brief phas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c845679595802fdeb2f9fdd0010e6b21
https://doi.org/10.1007/s11060-019-03227-7
https://doi.org/10.1007/s11060-019-03227-7
Autor:
Matteo Fabbri, Sheila Manemann, Cynthia Boyd, Jennifer Wolff, Alanna Chamberlain, Susan Weston, Kathleen Yost, Lila Finney Rutten, Joan Griffin, Jill Killian, Veronique Roger
Publikováno v:
Circulation. 137
Introduction: Little is known about the characteristics and resources that enable patients with heart failure (HF) to engage in effective self-management. To address this gap in knowledge, we measured personal and health care resources for self-manag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80a57d89e68fb77122660721a0cd8113
https://doi.org/10.1161/circ.137.suppl_1.p161
https://doi.org/10.1161/circ.137.suppl_1.p161
Autor:
Denise Yardley, Karyn Dyehouse, Aruna Mani, Carmen Calfa, David Drosick, Kathleen Yost, Diana Shipley, Raven Quinn, Robyn Young, Lindsey Finney, Chris Earwood, Mythili Shastry, John Hainsworth
Publikováno v:
Cancer Research. 75:P3-11
Background: Pathologic complete response (pCR) following neoadjuvant chemotherapy for locally advanced breast cancer strongly correlates with improved disease-free survival, rates of breast-conserving surgery, and provides an early indicator of treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20fe0c133f9e1d7eec81946f44c9c984
https://doi.org/10.1158/1538-7445.sabcs14-p3-11-08
https://doi.org/10.1158/1538-7445.sabcs14-p3-11-08
Autor:
Ritter, Kathleen Yost1
Publikováno v:
Journal of Counseling & Development. Sep85, Vol. 64 Issue 1, p42. 5p.